DOPC for Lipidic Nanoparticles Formulation

January 19, 2024

BlueskyReddit
Università degli Studi Milano-Bicocca
Industrial Biotechnologies
Graduate Student

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Avanti polar lipids

Product Name:

18:1 (Δ9-Cis) PC (DOPC)

Catalog Number:

850375

The study focuses on the development and optimization of a lipidic nanoparticles formulation as new drug delivery system for osteosarcoma.

Experimental Design and Results Summary

Application

DOPC was used as a lipidic component of our liposome nanoformulation

Starting Material

Tips

It easily hydrates, pay attention to keep it dry as much as possible

Results Summary

Adding DOPC in our formulation allowed us to obtain nanoparticles with good size and PDI. The results showed reliability and reproducibility.

DOI or PMID #

N/A

Image Gallery

Summary

The Good

Ideal candidate for mimicking natural cell membranes.

The Bad

Very sticky and difficult to manipulate.

The Bottom Line

Its biocompatibility and the ability to form bilayers to encapsulate drugs make DOPC a key player in our lipidic nanoformulation.

Join the discussion